MOCACARE, a Silicon Valley based company has launched MOCACuff, a FDA-approved wireless blood pressure monitor that fits comfortably on the wrist. Priced at $69.99, MOCACuff is the second product in the MOCACARE line that makes it easy to incorporate blood pressure monitoring into your everyday routine and receive instant, actionable insights to improve your health.MOCACARE first product, MOCAheart device uses thumb scans to measure heart rate, blood oxygen levels, and pulse wave velocity - a
Read More
American Heart Association
American Heart Association, Amazon Launch Cloud-Based Precision Medicine Data Marketplace
The American Heart Association (AHA) has announced a strategic collaboration with Amazon Web Services (AWS) to launch a secure cloud-based precision medicine data marketplace. The marketplace will include a vast array of curated rich datasets, that are centrally stored, easily searched and accessible, and managed on the AWS cloud. This platform enables researchers and clinicians to aggregate and analyze a rich breadth and depth of data including longitudinal cohorts, proteomic, genomic, and
Read More
AHA, IBM Watson Health, Welltok Partner to Transform Heart Health
The American Heart Association is teaming up with IBM Watson Health and Welltok to develop a first of its kind workplace health solution that leverages the cognitive computing power of IBM Watson. Powered by IBM Watson, AHA, IBM, and Welltok will create a new offering that combines AHA's science-based metrics and health assessments with cognitive analytics, delivered on Welltok's health optimization platform. The effort is intended to help alleviate the burden of cardiovascular diseases, which
Read More
Google, Heart Association Launch $50M Research Innovation Project to Fight Heart Disease
Alphabet Inc.’s Google Life Sciences (GLS) unit and the American Heart Association have announced a five-year, $50 million research collaboration to uncover the drivers of heart disease. Both organizations will each invest $25 million over five years to support novel strategies to understand, prevent, and reverse coronary heart disease and its consequences, such as heart failure and sudden cardiac death. The research collaboration marks the largest one-time research investment in AHA’s
Read More
